Business Context and Reporting Period
Company: Smith & Nephew plc (LSE:SN, NYSE:SNN)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: September 9, 2026
Context: The filing announces the pricing of a new senior note offering. Smith & Nephew is a global medical technology business focused on Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management, with approximately 17,000 employees and operations in around 100 countries.
Key Financial Metrics and Transaction Details
This filing details a specific capital market transaction rather than a full period financial report. Key figures include:
- New Debt Issuance: USD 700,000,000 in 5.750% Notes due 2036.
- Net Proceeds: USD 690,928,000 (after underwriting discounts).
- Closing Date: Scheduled for September 11, 2026.
- Historical Revenue: The company generated annual sales of USD 6.2 billion in 2025.
- Use of Proceeds: Funding a tender offer to purchase outstanding 2.032% Senior Notes due 2030, paying related fees, and general corporate purposes.
Note: The filing text does not provide current period revenue, profit, cash flow, or margin data for the six months ended September 9, 2026.
Material Changes and Strategic Actions
The primary material change is the refinancing of existing debt. The company is issuing new notes at a 5.750% coupon rate to replace or reduce its outstanding 2.032% Senior Notes due 2030. This action increases the interest rate on the specific tranche of debt being refinanced but extends the maturity date from 2030 to 2036.
Outlook, Risks, and Contingencies
Management Commentary: The company states it is "well-placed" to deliver its mission of "Life Unlimited" through its product portfolio and new technologies.
Risks and Contingencies: The filing includes a comprehensive list of forward-looking statement risks, including:
- Geopolitical conflicts in Europe and the Middle East.
- Economic conditions affecting healthcare providers and payers.
- Regulatory approvals, reimbursement decisions, and government actions.
- Product defects, recalls, and quality management compliance.
- Supply chain disruptions and cybersecurity threats.
- Foreign exchange volatility and changes in taxation regulations.
- Impacts of AI deployment and climate change events.
Legal Restrictions: The Notes are not available to retail investors in the United Kingdom or the European Economic Area (EEA).
Investor Verification Checklist
- Verify the final closing of the USD 700 million bond issue on September 11, 2026.
- Confirm the success and final terms of the tender offer for the 2.032% Senior Notes due 2030.
- Review the full prospectus filed with the SEC for detailed risk factors and underwriting terms.
- Monitor the impact of the higher 5.750% interest rate on future interest expense and net income.
- Check subsequent filings for updates on the 2026 interim financial results referenced in the forward-looking statements.